Welcome to our dedicated page for Vital Farms SEC filings (Ticker: VITL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vital Farms, Inc. (Nasdaq: VITL) is a Certified B Corporation and Delaware public benefit corporation that focuses on pasture-raised eggs and egg-based foods such as shell eggs, butter, hard-boiled eggs, and liquid whole eggs. As a publicly traded company, Vital Farms files regular reports and current reports with the U.S. Securities and Exchange Commission (SEC), providing detailed information on its financial performance, risks, governance, and strategic initiatives.
On this page, you can review Vital Farms’ SEC filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its business model, farm network, product categories, and risk factors related to supply, consumer demand, agricultural disease, regulation, and macroeconomic conditions. These filings also discuss its status as a public benefit corporation, its stakeholder-focused objectives, and its emphasis on humane treatment of farm animals and sustainable farming practices.
Current reports on Form 8-K offer more immediate updates. Recent 8-K filings have covered quarterly financial results, long-term net revenue targets, and governance matters such as the appointment of a new independent director and the frequency of advisory Say-on-Pay votes. An amended 8-K explains the company’s decision to hold non-binding advisory votes on executive compensation annually, following stockholder preferences.
Stock Titan’s platform enhances access to these documents with AI-powered summaries that explain key sections of Vital Farms’ filings in plain language. Investors can quickly understand highlights from lengthy 10-K and 10-Q reports, see what management disclosed in 8-K earnings releases, and track governance items without reading every page. Real-time updates from EDGAR ensure that new filings appear promptly, while AI-generated overviews help readers identify significant changes, recurring themes, and references to long-term targets and capital projects.
For users monitoring insider and governance activity, this page also centralizes access to forms and disclosures related to directors and executive compensation policies as referenced in Vital Farms’ filings.
Issuer submitted a Form 144 to report intended resale of 6,500 shares of Common Stock. The filing lists the securities as restricted stock vesting under a registered plan and identifies the transaction date as 03/13/2026. The sale is reported through Morgan Stanley Smith Barney LLC as the broker-dealer.
VITL filed a Form 144 noting a proposed sale of 6,680 shares of Common Stock. The filing states the shares relate to restricted stock vesting under a registered plan and lists 03/13/2026 as the transaction date with NASDAQ as the market. The broker is Morgan Stanley Smith Barney LLC.
Vital Farms, Inc. major shareholder Matthew Ohayer filed an amended Form 4 reporting an open-market sale of 15,000 shares of common stock at a weighted average price of $20.33 per share on March 2, 2026, executed under a pre-arranged Rule 10b5-1 trading plan.
After the sale, he directly holds 6,326,190 shares. The filing also reflects 400,000 shares held indirectly by a former spouse, over which he has sole voting control but no pecuniary interest. The amendment corrects the previously reported shares sold and shares beneficially owned.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice relating to the proposed sale of 6,020 shares of Common stock on 03/12/2026.
The filing identifies the transaction as related to restricted stock vesting under a registered plan and lists NASDAQ as the market. The filing names the seller role as Issuer.
Vital Farms director Karl Khoury bought 5,000 shares of Common Stock in an open-market purchase at a weighted average price of $18.45 per share. After this transaction, he directly owns 119,789 shares. The shares were acquired in multiple trades at prices ranging from $18.41 to $18.47.
Vital Farms, Inc. executive Peter Nicholas Pappas, CSO and President, Eggs, reported two stock transactions. He received a grant of 19,558 shares of common stock as a restricted stock unit award, which vests in three equal annual installments starting on March 5, 2027, contingent on continued service. In a separate transaction, 1,019 shares at $20.30 per share were withheld by the company to cover his tax obligations. Following these transactions, he directly holds 83,999 shares of Vital Farms common stock.
OHAYER MATTHEW reported acquisition or exercise transactions in this Form 4 filing.
Vital Farms, Inc. insider Matthew Ohayer reported an award of 5,530 restricted stock units of common stock. These RSUs vest on March 5, 2027, subject to his continuous service with Vital Farms through the vesting date.
The RSU award had been previously approved by the board of directors for services provided before his retirement. Ohayer now serves as a non-employee advisor under a resignation agreement. Following the RSU award, he directly holds 6,326,720 common shares. An additional 400,000 shares are held indirectly by a former spouse; he has sole voting control over those shares but no pecuniary interest.
Vital Farms, Inc. Chief Financial Officer Thilo Wrede reported two stock-related transactions involving the company’s common stock. On March 5, 2026, he acquired 25,138 shares through a restricted stock unit award that carries no purchase price. According to the award terms, these RSUs vest in three equal annual installments starting on March 5, 2027, as long as he remains in continuous service with the company.
On March 4, 2026, 1,769 shares were withheld at a price of $20.30 per share to cover withholding tax obligations, meaning this was a tax-related disposition back to the issuer rather than an open-market sale. Following these transactions, he continues to hold a significant direct ownership position in Vital Farms common stock.
Vital Farms, Inc. Chief People Officer Van Hoven Reena Chauhan reported mixed equity transactions in company common stock. On March 5, 2026, she received a grant of 13,675 restricted stock units (RSUs) at no cost, vesting in three equal annual installments starting March 5, 2027, contingent on continued service.
On March 4, 2026, 855 shares of common stock at $20.30 per share were disposed of to cover withholding tax obligations, with shares withheld by the issuer rather than sold in the open market. Following these transactions, her directly held common stock positions reflected updated share totals as reported.
Vital Farms, Inc. reported insider equity activity for CMO and GM, Butter, Kathryn McKeon. She acquired 15,184 shares of common stock on a grant described as a restricted stock unit award that vests in three equal annual installments starting March 5, 2027, subject to her continuous service.
Separately, on an earlier date, 784 shares of common stock were disposed of to the issuer to satisfy a withholding tax obligation, reflecting a tax-withholding disposition rather than an open-market sale.